L

Louise R. Rodino‐Klapac

Sarepta Therapeutics (United States)

ORCID: 0000-0002-8966-5177

Publishes on Muscle Physiology and Disorders, Virus-based gene therapy research, Neurogenetic and Muscular Disorders Research. 172 papers and 10.1k citations.

PubIndex Score97Top 3%How it's scored

172Publications

10.1kTotal Citations

First publication: 2000First senior author: 2012

Muscle Physiology and Disorders Virus-based gene therapy research Neurogenetic and Muscular Disorders Research CRISPR and Genetic Engineering CAR-T cell therapy research

Top publicationsby citations

Eteplirsen for the treatment of Duchenne muscular dystrophy

Jerry R. Mendell, Chris Shilling, Kathleen R. Melia et al.|Annals of Neurology|2013

Cited by 793

Dystrophin Immunity in Duchenne's Muscular Dystrophy

Jerry R. Mendell, Christopher M. Walker, Katherine Campbell et al.|New England Journal of Medicine|2010

Cited by 655

Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy

Jerry R. Mendell, Louise R. Rodino‐Klapac, Zarife Sahenk et al.|JAMA Neurology|2020

Cited by 387

Gentamicin‐induced readthrough of stop codons in duchenne muscular dystrophy

Vinod Malik, Jerry R. Mendell, Louise R. Rodino‐Klapac et al.|Annals of Neurology|2010

Cited by 272

Sustained alpha‐sarcoglycan gene expression after gene transfer in limb‐girdle muscular dystrophy, type 2D

Jerry R. Mendell, K. Reed Clark, Louise R. Rodino‐Klapac et al.|Annals of Neurology|2010

Cited by 243